ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992

Carter Request Only $878.8 Million For NCI

January 27, 1978

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011